Team
health

Levothyroxine Dosage Calculator

Levothyroxine replacement therapy forms the cornerstone of hypothyroidism management in adults and adolescents. Dosing depends on body weight, height, age, cardiac status, and baseline free thyroxine (FT4) concentration. This calculator applies established weight-based protocols to estimate an appropriate starting dose, accounting for lean body weight in overweight patients using the Devine formula. Clinicians use this to initiate therapy or adjust doses during titration.

Last updated:

Creators Łucja Zaborowska, MD, PhD
8,038 people find this calculator helpful

Understanding Hypothyroidism

Hypothyroidism occurs when the thyroid gland fails to produce sufficient T3 (triiodothyronine) and T4 (thyroxine) to sustain normal metabolic function. The pituitary gland regulates thyroid activity via thyroid-stimulating hormone (TSH); when thyroid hormone levels fall, TSH rises in an attempt to stimulate increased production. Inadequate thyroid hormone affects virtually every organ system—metabolism slows, energy production declines, and compensatory mechanisms become overwhelmed.

Common manifestations include fatigue, cold intolerance, weight gain, cognitive slowing, depression, dry skin, and menstrual irregularities. Severity varies widely depending on the degree of hormone deficiency, patient age, comorbidities, and how rapidly the condition developed. Left untreated, severe hypothyroidism can progress to myxedema coma, a life-threatening emergency.

Levothyroxine as Thyroid Replacement

Levothyroxine is a synthetic form of T4 (thyroxine) developed in 1927 and now listed on the WHO Model List of Essential Medicines. Once absorbed, the body peripherally converts T4 to the more active T3 as needed. Unlike thyroid extracts, synthetic levothyroxine offers consistent potency and predictable pharmacokinetics.

The hormone acts on target tissues throughout the body, restoring normal thermogenesis, protein synthesis, and metabolic rate. When dosed appropriately, levothyroxine replacement effectively resolves hypothyroid symptoms and normalizes TSH, preventing long-term complications such as infertility, neuropathy, cognitive impairment, and cardiac dysfunction.

Dosage Calculation Formula

The levothyroxine starting dose is determined by multiplying the patient's lean body weight (or actual weight if lower) by a weight-adjustment factor derived from the current FT4 deficit. The Devine formula estimates ideal body weight to account for excessive adiposity, since adipose tissue contributes little to thyroid hormone metabolism.

Men: Dose = FT4 adjustment × min(actual weight, 50.0 + 2.3 × [(height − 1.524) ÷ 0.0254])

Women: Dose = FT4 adjustment × min(actual weight, 45.5 + 2.3 × [(height − 1.524) ÷ 0.0254])

  • FT4 adjustment — Scaling factor based on free thyroxine deficit; higher values indicate greater hormone deficiency
  • height — Patient height in metres; used to calculate ideal body weight via the Devine formula
  • weight — Patient's actual body weight in kilograms; the calculator uses the lower of actual or ideal weight

Subclinical Hypothyroidism and Treatment Decisions

Subclinical hypothyroidism is characterised by elevated TSH (typically >4.5 mU/L) with normal or low-normal free T4 and T3 levels. Many patients remain asymptomatic, and the condition may never progress. However, risk of progression to overt hypothyroidism increases significantly if baseline TSH exceeds 10 mU/L or if thyroid peroxidase (TPO) antibodies are present.

Treatment is not automatically indicated for mild elevations. Decisions depend on age, symptomatology, antibody status, cardiac risk, and pregnancy status or desire. Younger, asymptomatic patients with TSH <10 mU/L and negative antibodies may be monitored. Older adults, those with cardiovascular disease, pregnant women, or those planning pregnancy warrant more aggressive treatment thresholds.

Critical Considerations for Levothyroxine Dosing

Several factors significantly influence levothyroxine efficacy and safety; overlooking them leads to therapeutic failure or adverse effects.

  1. Absorption and Drug Interactions — Levothyroxine absorption is maximal on an empty stomach. Administer at least 30–60 minutes before breakfast, or alternatively at bedtime (≥3 hours after the last meal). Iron supplements, calcium, magnesium, multivitamins, PPIs, and H2-blockers all impair absorption—space dosing by at least 4 hours.
  2. Age and Cardiac Status — Elderly patients and those with coronary artery disease, arrhythmias, or hypertension tolerate rapid TSH normalisation poorly. Begin at lower doses (typically 25–50 mcg daily) and titrate slowly over 6–8 weeks to avoid precipitating angina, atrial fibrillation, or acute decompensation.
  3. Body Weight Bias — The calculator applies lean body weight, not total body weight, because excess adipose tissue does not significantly contribute to levothyroxine distribution or metabolism. Overweight or obese patients often require lower absolute doses than their actual weight would suggest.
  4. TSH Target Variation by Age and Indication — Target TSH ranges vary: younger patients generally aim for 0.5–2.0 mU/L, older adults 2.0–4.0 mU/L to reduce cardiac risk, and those with previous thyroid cancer may require suppressive dosing (TSH <0.1 mU/L). Pregnancy typically calls for TSH <2.5 mU/L in the first trimester.

Frequently Asked Questions

How is hypothyroidism formally diagnosed?

Clinical suspicion based on symptoms warrants thyroid function testing. A healthcare provider measures TSH first; if elevated, free T4 is checked. TSH >4.5 mU/L with low-normal or low free T4 confirms overt hypothyroidism. TPO antibody testing may be ordered to identify autoimmune (Hashimoto) thyroiditis, the most common cause. In subclinical hypothyroidism, TSH is elevated but free T4 remains normal, necessitating a discussion about risks and benefits of early treatment versus surveillance.

What are the earliest signs of levothyroxine effectiveness?

Energy levels typically improve within 2–4 weeks as metabolic rate increases. Cognitive clarity and mood elevation follow, often accompanied by normalisation of appetite and cessation of further weight gain. Full symptom resolution and stable TSH usually require 6–8 weeks post-initiation or dose adjustment, as the body reaches a new equilibrium. Repeat TSH testing 6–8 weeks after any dose change guides further titration toward the individual's target range.

Why does the calculator use ideal body weight rather than actual weight?

The Devine formula estimates ideal body weight because excess adipose tissue is metabolically inert with respect to levothyroxine kinetics. Using actual weight in obese patients would overestimate the required dose, increasing the risk of iatrogenic hyperthyroidism and complications such as atrial fibrillation, osteoporosis, and cardiac strain. The calculator employs the lower of actual or ideal weight to prevent overdosing while respecting patients who are already at or below ideal weight.

Can levothyroxine be safely used during pregnancy?

Yes; untreated or undertreated hypothyroidism during pregnancy increases miscarriage risk and impairs fetal neurodevelopment. Pregnancy increases levothyroxine requirements by 25–50% due to expanded plasma volume, increased renal clearance, and placental metabolism. TSH targets tighten to <2.5 mU/L in the first trimester. Most women require dose increases of 25–50 mcg upon conception or when pregnancy is confirmed. Frequent monitoring (every 4–6 weeks) and dose adjustments are essential.

What happens if the dose is too high?

Excessive levothyroxine causes iatrogenic hyperthyroidism, with symptoms including tremor, palpitations, anxiety, heat intolerance, and weight loss despite normal or increased appetite. Chronic overtreatment accelerates bone loss (increasing osteoporosis and fracture risk), increases atrial fibrillation incidence, and exacerbates angina in susceptible patients. TSH suppression below 0.1 mU/L for prolonged periods is particularly risky in older adults and those with cardiac disease. Dose reduction and TSH retesting 6–8 weeks later typically reverse symptoms.

How often should TSH be monitored after starting levothyroxine?

Initial monitoring occurs 6–8 weeks after starting therapy or adjusting the dose, allowing sufficient time for steady state. Once stable, asymptomatic patients may be monitored annually. However, certain situations warrant closer surveillance: pregnancy (every 4–6 weeks), recent dose changes, concurrent medications affecting absorption, age >65, or significant comorbidities. Patients on suppressive therapy for thyroid cancer require TSH checks every 3–6 months. Regular monitoring prevents both under- and over-treatment and catches compliance issues or drug interactions early.

health
ACFT Calculator

More health calculators (see all)

Peptide Dosage Calculator Diabetes Risk Calculator Reverse Due Date Calculator Mask vs. No Mask Calculator Anion Gap Calculator Egg Freezing Calculator Sodium in Salt Calculator Micrograms to IU Converter